tiprankstipranks
Trending News
More News >
Myriad Genetics (MYGN)
NASDAQ:MYGN
Advertisement

Myriad Genetics (MYGN) Revenue

Compare
406 Followers

Myriad Genetics Revenue

Myriad Genetics had a revenue of 213.10M in the quarter ending Jun 30, 2025, with 8.78%. This bring the company's revenue in the last twelve months to 832.90M, Decreased 0.19%. In the fiscal year ending Dec 31, 2024, Myriad Genetics had annual revenue of 837.60M with 11.21% growth.
Revenue (ttm)
832.90M
Revenue Growth
3.83%
P/S Ratio
0.77
Revenue/Employee
$310,222
Employees
2,700
Market Cap
$642.94M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
837.60M84.40M+11.21%
Dec 31, 2023
753.20M74.80M+11.03%
Dec 31, 2022
678.40M-12.20M-1.77%
Dec 31, 2021
690.60M133.60M+23.99%
Dec 31, 2020
557.00M-81.60M-12.78%
Dec 31, 2019
638.60M-212.50M-24.97%
Dec 31, 2018
851.10M78.50M+10.16%
Dec 31, 2017
772.60M1.20M+0.16%
Dec 31, 2016
771.40M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis